Albert J. R. Heck (1964) received his PhD in 1993 from the University of Amsterdam. He worked till 1996 as a postdoctoral researcher at Stanford University and Sandia National Laboratories (USA). In 1996 he became senior research fellow and later lecturer at the University of Warwick (UK). Since 1998 he is professor in Biomolecular Mass Spectrometry and Proteomics at Utrecht University (NL).
Heck is among others recipient of the Field and Franklin Award (ACS), the Krebs Medal (FEBS), Thomson Award (IMSC) and the NWO Spinoza Prize. He is member of EMBO and the Royal Netherlands Academy of Sciences and Arts. His research focuses on the development and applications of mass spectrometry-based proteomics and structural biology. Heck pioneered technologies for phospho-enrichment, and the use of alternative proteases and hybrid peptide fragmentation techniques. Besides, Heck is also known for his expertise in structural biology, being a pioneer in both native mass spectrometry and cross-linking mass spectrometry.
University of Nebraska Medical Center
Dr. Gundry is Professor and Vice Chair of Cellular and Integrative Physiology, Assistant Chief of Basic and Translational Research for the Division of Cardiology and is the Director of the CardiOmics Program at the University of Nebraska Medical Center. The Gundry lab applies mass spectrometry technologies for advancing basic and translational cardiac research and clinical care. Through development and application of innovative approaches and bioinformatic tools to study cell surface glycoproteins and glycans, the Gundry lab aims to answer outstanding questions in stem cell and cardiac biology and disease. Dr. Gundry is a Council Member of HUPO, Co-Chair of the HUPO B/D HPP Cardiovascular Initiative, is on the Board of Directors of US HUPO, and is an Associate Editor of the Journal of Molecular and Cellular Cardiology. The Gundry lab is funded by the American Heart Association, Juvenile Diabetes Research Foundation, and National Institutes of Health.
Harvard Medical School, MGB Center for COVID Innovation
David R. Walt is the Hansjörg Wyss Professor of Bioinspired Engineering at Harvard Medical School and Professor of Pathology at Harvard Medical School and Brigham and Women’s Hospital, is a Core Faculty Member of the Wyss Institute at Harvard University, Associate Member at the Broad Institute, and is a Howard Hughes Medical Institute Professor. Dr. Walt is co-Director of the Mass General Brigham Center for COVID Innovation. Dr. Walt is the Scientific Founder of Illumina Inc., Quanterix Corp., and has co-founded several other life sciences startups. He has received numerous national and international awards and honors for his fundamental and applied work in the field of optical microwell arrays and single molecules He has received numerous awards and honors, including the 2017 American Chemical Society Kathryn C. Hach Award for Entrepreneurial Success, the 2016 Ralph Adams Award in Bioanalytical Chemistry, the 2014 American Chemical Society Gustavus John Esselen Award, the 2013 Analytical Chemistry Spectrochemical Analysis Award, the 2013 Pittsburgh Analytical Chemistry Award, and the 2010 ACS National Award for Creative Invention. He is a member of the U.S. National Academy of Engineering, the U.S. National Academy of Medicine, a Fellow of the American Academy of Arts and Sciences, a Fellow of the American Institute for Medical and Biological Engineering, a Fellow of the American Association for the Advancement of Science, a Fellow of the National Academy of Inventors, and is inducted in the US National Inventors Hall of Fame
Massachusetts Institute of Technology
Professor Michael S. Strano is currently the Carbon P. Dubbs Professor in the Chemical Engineering Department at the Massachusetts Institute of Technology. He received is B.S from Polytechnic university in Brooklyn, NY and Ph.D. from the University of Delaware both in Chemical Engineering. He was a post doctoral research fellow at Rice University in the departments of Chemistry and Physics under the guidance of Nobel Laureate Richard E. Smalley. From 2003 to 2007, Michael was an Assistant Professor in the Department of Chemical and Biomolecular Engineering at the University of Illinois at Urbana-Champaign before moving to MIT. His research focuses on biomolecule/nanoparticle interactions and the surface chemistry of low dimensional systems, nano-electronics, nanoparticle separations, and applications of vibrational spectroscopy to nanotechnology.
Michael is the recipient of numerous awards for his work, including a 2005 Presidential Early Career Award for Scientists and Engineers, a 2006 Beckman Young Investigator Award, the 2006 Coblentz Award for Molecular Spectroscopy, the Unilever Award from the American Chemical Society in 2007 for excellence in colloidal science, and the 2008 Young Investigator Award from the Materials Research Society and the 2008 Allen P. Colburn Award from the American Institute of Chemical Engineers. From 2014 to 2015 he served as member of the Defense Science Study Group, and is currently an editor for
the journals Carbon and Protocols in Chemical Biology. Michael was elected to the National Academy of Engineering in 2017.
John A. McLean is Stevenson Professor of Chemistry, Chair of the Department of Chemistry, Past Chair of the Faculty Senate, Director of the Center for Innovative Technologies, Deputy Director of the Institute for Integrative Biosystems Research and Education at Vanderbilt University. He received his Ph.D. from George Washington University, was a postdoctoral fellow at Forschungszentrum Jülich in Germany with Prof. Dr. Sabine Becker, and a postdoctoral at Texas A&M University with Prof. David H. Russell before joining the Vanderbilt Faculty as an assistant professor in 2006. McLean and colleagues focus on the conceptualization, design, and construction of structural mass spectrometers, specifically targeting complex samples in systems, synthetic, and chemical biology. His group applies these strategies to forefront translational research areas in drug discovery, precision medicine, and ‘human-on-chip’ synthetic biology platforms. He served on the board of directors for the American Society for Mass Spectrometry and serves in an editorial role on the boards of several leading scientific journals. He has been honored to work closely with the NAS and NSF in several roles, including recently co-authoring an NSF report on big data science in chemistry. He has received many professional and teaching awards including his laboratory being designated as a Waters Center of Innovation and an Agilent Thought Leader Laboratory for their work in ion mobility-mass spectrometry and translational biosciences. He has published over 150 manuscripts and 30 patents in the areas of innovative bioanalytical chemistry and quantitative sciences.
University of Texas at Austin
Dr. Jennifer S. Brodbelt is the Rowland Pettit Centennial Professor of Chemistry at the University of Texas at Austin and is also serving as Chairperson. She earned her B.S. degree in chemistry at the University of Virginia and her doctorate in chemistry at Purdue University under the supervision of Prof. Graham Cooks. After a post-doctoral position at the University of California at Santa Barbara with Prof. Mike Bowers, she began her academic career at the University of Texas. Her research interests focus on the development and application of photodissociation mass spectrometry for characterization of the structures and modifications of biological molecules, including peptides, proteins, nucleic acids, oligosaccharides, and lipids. She served as the Director of Graduate Education in the Department of Chemistry for over 20 years and recently became Chairperson in 2019. She serves as an Associate Editor for the Journal of the American Society for Mass Spectrometry, and she served as President of the American Society for Mass Spectrometry from 2014-2016.
Baylor College of Medicine
Prof. Livia Schiavinato Eberlin is an Assistant Professor in the Departments of Chemistry, Oncology and Diagnostic Medicine at the University of Texas at Austin, and an adjunct Assistant Professor in the Department of Surgery at Baylor College of Medicine. Dr. Eberlin received her B.S. in Chemistry in 2008 from the State University of Campinas, her Ph.D. in Analytical Chemistry in 2012 from Purdue University under the guidance of Prof. Graham Cooks, and pursued her postdoctoral research with Prof. Richard Zare in the Department of Chemistry at Stanford University. In 2016, Prof. Eberlin started her independent career at The University of Texas at Austin. Her research in mass spectrometry has been recognized through grants and awards, including a NIH K99/R00 Pathway to Independence Award, a Moore Inventor Fellowship, and a MacArthur Fellowship. Her research program centers around the development and application of novel mass spectrometry technologies in health-related research, with a particular focus on disease detection and diagnosis.
Cedars Sinai Medical Center, Heart Institute
Dr. Fert-Bober is an assistant professor at Cedars-Sinai, Medical Center, Smidt Heart Institute and the Advanced Clinical Biosystems Research Institute. Dr. Fert-Bober lead a basic translational research program focused on solving the mysteries of how and why systemic autoimmunity develops and persists in order to guide the discovery of better clinical tests and improved treatments. The Fert-Bober’s lab uses traditional methodology and cutting-edge high density array technology and mass spectrometry with innovative statistical methods to discover new autoantibody targets as well as novel features of antibody and autoantibody reactivity in rheumatoid arthritis and other chronic diseases. In addition to understanding the role of citrullinated proteins in the physiology and pathophysiology process, her research group also encompasses the areas of methods development and bioinformatics, including citrullination identification pipeline, called “CitFinder”, mass spectrometry-based quantification of specific PAD isoforms in complex biological matrix and currently establishing the molecular model for binding partners. The Fert-Bober lab is funded by Congressionally Directed Medical Research Programs, National Institutes of Health and Cedars-Sinai Precision Health Foundation.
Buck Institute, Novato, CA, USA
Dr. Birgit Schilling works at the Buck Institute for Research on Aging in the San Francisco Bay Area since 2000, where she has her own lab. Dr Schilling is interested in translational research and any research that may aim towards therapeutic interventions to improve human aging or disease. Dr. Schilling’s uses modern proteomics technologies, such as data-independent acquisitions to investigate basic mechanisms of aging, as well as using this knowledge to develop biomarkers of aging and disease. Additional key projects in the lab investigate the dynamic role of post-translational modifications (PTMs) during signaling and specifically in the context of metabolic diseases, neurodegenerative diseases, cancer and aging. Combination of data-independent acquisitions with PTM research has allowed to gain better understanding for modification site localization and PTM crosstalk.
Baylor College of Medicine
Dr. Young earned a bachelor’s degree in Chemistry, from the University of California, Berkeley. He worked in industry for 2 year providing mass spectrometry expertise to biotechnology startups. In 2002 he joined Lawrence Livermore National Laboratory where he led mass spectrometry-based biosecurity research efforts. He received a DOE Advanced Scholars Program Graduate Fellowship to support his graduate work with Carlito Lebrilla at the University of California, Davis. He then joined the laboratory of Ben Garcia at Princeton University as a National Cancer Institute postdoctoral fellow, where he focused on proteomic analysis of histones and histone post-translational modifications and their role in DNA damage response and repair. In 2012 started his own research program as the Director of Biological Applications in the Ion Cyclotron Resonance Program at the National High Magnetic Field Laboratory in Tallahassee Florida. In 2016 in joined the faculty in the Verna and Marrs McLean Department of Biochemistry and Molecular Biology at Baylor College of Medicine in Houston, TX. He has published almost 60 papers, received multiple awards, including the Robert Cotter New Investigator award from the US Human Proteome Organization, and his work is currently funded by multiple NIH grants. He has developed analytical methods that enable a more complete understanding of the regulation of the genome through the use of quantitative Top-Down Proteomics to observe the co-occurrence of multiple post-translational modifications on the same single molecule. These single molecule combinations, or proteoforms, are essential to epigenetic regulation of the genome. He also develops mass spectrometry-based methods to reveal the mechanisms of action of small molecule inhibitors of the epigenetic system and how to apply drugs in combination to overcome disease such as cancer and neurodegeration.
Associate Editor, Analytical Chemistry
Prof. Boris Mizaikoff joined the faculty at Ulm University, Germany, as a Chaired Professor and Director at the Institute of Analytical and Bioanalytical Chemistry in 2007 with prior appointments at the Vienna University of Technology (Austria), and at the Georgia Institute of Technology (USA). Since 2021, he is also Director at the Hahn-Schickard Institute for Microanalysis Systems in Ulm. His research interests focus on optical chem/bio sensors, tailored (bio)molecular recognition interfaces, molecularly imprinted materials, system miniaturization and integration, and multifunctional (nano)analytical techniques with applications in environmental analysis, process monitoring, and biomedical diagnostics. He is the recipient of several awards including the RSC Emerging Technologies Award by the Royal Society of Chemistry, the Craver Award by the Coblentz Society, and the Pittsburgh Conference Achievement Award by the Society for Analytical Chemists of Pittsburgh. He has been elected Fellow of the Society of Applied Spectroscopy, the Royal Society of Chemistry, and the American Association for the Advancement of Science. He is also an Associate Editor of Analytical Chemistry. In his free time, he is an amateur yet passionate ultra-long-distance-trail-runner!
University of Oxford
Associate Editor, JACS
Carol Robinson holds the Chair of Dr. Lee’s Professor of Chemistry at the University of Oxford and is the first Director of the Kavli Institute for Nanoscience Discovery at Oxford. She is recognised for establishing mass spectrometry as a viable technology to study the structure, function and interactions of proteins and their complexes. Carol graduated from the Royal Society of Chemistry in 1979 and completed her PhD at the University of Cambridge, UK. She took a career break of eight years to bring up her children, later becoming Professor of Mass Spectrometry at the University of Cambridge (2001-2009). She has occupied her current professorial position in Oxford Chemistry since 2009. Her work has attracted over twenty awards and prizes including most recently, the Othmer Gold Medal from the Science History Institute (2020), Royal Medal A from the Royal Society, the Novozymes Prize from the Novo Nordisk Foundation, the Stein and Moore Award from the Protein Society (2019) and the Field and Franklin Award from the American Chemical Society (2018). Carol is the former President of the Royal Society of Chemistry (2018-2020) and a Foreign Associate of the National Academy of Sciences USA. She was awarded a DBE in 2013 for services to science and industry.
Associate Editor, Analytical Chemistry
Dr. Yoshinobu Baba received his PhD degree in 1986 from Kyushu University. He was an Assistant Professor at Oita University and an Associate Professor at Kobe Pharmaceutical University before being promoted to full professor at The University of Tokushima in 1997. He moved to Nagoya University in 2004. He is now a Professor in the Department of Chemistry and Biotechnology, School of Engineering, a Professor in the Department of Advanced Medical Science, School of Medicine, and a Director of the Institute of Nano-Life-Systems, Nagoya University. He is also a Director General of the Institute for Quantum Life Science, a Director of Quantum Life Science Research Hub, National Institutes for Quantum and Radiological Science and Technology, a Research Supervisor of JST CREST “Extracellular fine particles” Project, and a Project Leader of MEXT Q-LEAP program on quantum life science. He is a co-initiator for the world’s largest Nanotech International Meeting. He is a general chair of numerous international meetings (microTAS, MSB, nanotech). He is an Associate Editor of Anal. Chem. of ACS and serving to over 10 scientific journals as an editorial/advisory board member. He has been admitted as a Fellow of the Royal Society of Chemistry and received over 90 awards for his contributions in nanobiotechnology. Dr. Baba’s research studies are directed at the development of nanobiodevices for omics, systems biology, medical diagnosis, tissue engineering, and molecular imaging. He is the author or co-author of 1,050 publications, including research papers, proceedings, reviews, and books and is also an inventor of over 100 patents. He has delivered more than 1,010 plenary and invited lectures at conferences. His work has been cited on 493 occasions by newspapers, television, and web news.
University of Virginia
Dr. B. Jill Venton is a Professor and Chair of the Department of Chemistry at the University of Virginia. She is also affiliated with the Neuroscience Graduate Program and the UVA Brain Institute. She received her BS in Chemistry from University of Delaware, her PhD in Chemistry from UNC-Chapel Hill (with Mark Wightman), and did postdoctoral research at University of Michigan (with Bob Kennedy). Dr. Venton started her career at University of Virginia in 2005, and has worked her way up the ranks from Assistant Professor all the way to Full Professor and Department Chair. Her research interests are in developing analytical chemistry tools for neuroscience research and she specializes in developing electrochemical sensors. Applications include understanding brain changes in diseases ranging from Parkinson disease, to addiction, to stroke, and aging. She has published more than 90 scientific papers, has 3 patents, and has won numerous awards. Dr. Venton is also a passionate teacher and has developed new classes with active learning components for the undergraduate analytical chemistry curriculum. At home, she has 2 children who keep her busy.
Beijing Normal University
Associate Editor, ACS Sensors
Lanqun Mao is currently a Professor of the College of Chemistry at Beijing Normal University. He has enormous experience in the area of in vivo electrochemistry. His group has been working at the interface of electroanalytical chemistry and neuroscience, developing electrochemical approaches through tuning electron transfer and ion transport to understanding brain chemistry in single vesicles, single cells, brain slices and ultimately a living brain. He has demonstrated a record of successful and productive research projects in the related area, and his expertise and experience have led to more than 330 research papers and more than 40 plenary/invited talks in international conferences. He is currently an Associate Editor at ACS Sensors. His advice to young researchers is to be different and novel.
University of California-Berkeley
Markita Landry is an assistant professor in the department of Chemical and Biomolecular Engineering at the University of California, Berkeley. She received a B.S. in Chemistry and a B.A. in Physics from the University of North Carolina at Chapel Hill, a Ph.D. in Chemical Physics and a Certificate in Business Administration from the University of Illinois at Urbana-Champaign, and completed an NSF postdoctoral fellowship in Chemical Engineering at the Massachusetts Institute of Technology.
Her current research centers on the development of synthetic nanoparticle-polymer conjugates for imaging neuromodulation in the brain, and for the delivery of genetic materials into plants. The Landry lab exploits the highly tunable chemical and physical properties of nanomaterials for the creation of bio-mimetic structures, molecular imaging, and plant genome editing. She is also on the scientific advisory board of Terramera and on the scientific advisory board of Chi-Botanic. She is a recent recipient of over 20 early career awards, including awards from the Brain and Behavior Research Foundation, the Burroughs Wellcome Fund, the DARPA Young Investigator program, the Beckman Young Investigator program, the Howard Hughes Medical Institute, the NSF CAREER award, is a Sloan Research Fellow, an FFAR New Innovator, and is a Chan-Zuckerberg Biohub Investigator.
The University of California, Santa Barbara
Kevin Plaxco is a Professor at the University of California, Santa Barbara, with shared appointments between the Department of Chemistry and Biochemistry, the Department of Mechanical Engineering, and the Biomolecular Science and Engineering Graduate Program. Prior to joining the University of California at Santa Barbara in 1998 Dr. Plaxco received his Ph.D. from Caltech and performed postdoctoral studies at Oxford and the University of Washington. Dr. Plaxco has co-authored more than 180 papers on protein folding, protein dynamics, folding-based biosensors and folding-based smart materials. He has also co-authored a popular science book on Astrobiology and more than a dozen patents. He is actively involved in the commercialization of the novel technologies emerging from his laboratory and serves on the scientific advisory boards of a half dozen companies.
The University of Manchester
Perdita Barran is the Chair of Mass Spectrometry in the Department of Chemistry and the Director of the Michael Barber Centre for Collaborative Mass Spectrometry at the Manchester Institute of Biotechnology, The University of Manchester, U.K. Prof. Barran’s research interests include biological mass spectrometry; Instrument and technique development; Protein structure and interactions; Dynamic and Disordered Systems; Parkinson’s disease Diagnostics; HDX-MS; Proteomics; and Molecular modeling. She is a Fellow of the Royal Society of Chemistry and was awarded the Theophilius Redwood Award from the RSC in 2019, Researcher of the Year 2020 from the University of Manchester, and the ACS Measurement Science Lectureship Award in 2021. In 2020, she co-founded the COVID-19 Mass Spectrometry coalition and currently leads a multi-omic consortium in the UK which aims to identify biomarkers that are risk factors to indicate the severe and long-term progression of Sars-CoV-2 infection.
Associate Editor, ACS Applied Bio Materials
Christy Haynes is the Distinguished McKnight University Professor at the University of Minnesota where she leads the Haynes Research Group, a lab dedicated to applying analytical and nanomaterials chemistry in the context of biomedicine, ecology, and toxicology. Professor Haynes completed her undergraduate work at Macalester College in 1998 and earned a Ph.D. in chemistry at Northwestern University in 2003 under the direction of Richard P. Van Duyne. Before joining the faculty at the University of Minnesota in 2005, Haynes performed postdoctoral research in the laboratory of R. Mark Wightman at the University of North Carolina, Chapel Hill. Among many honors, she has been recognized as an Alfred P. Sloan Fellow, a Searle Scholar, a Dreyfus Teacher-Scholar, and a National Institutes of Health “New Innovator.” In addition to wide recognition for her research contributions, including over 200 peer-review publications, she has been recognized by her university as an Outstanding Postdoctoral Mentor and the Sara Evans Faculty Woman Scholar/Leader Award. Professor Haynes is currently the Associate Head of the University of Minnesota Department of Chemistry, the Associate Director of the National Science Foundation-funded Center for Sustainable Nanotechnology, and an Associate Editor for the journal Analytical Chemistry.
Haydn Boehm is the Head of Commercial Marketing for Merck’s Connected Lab digital program and has over 20 years’ experience in marketing and business development within the life scientific sector. Haydn has a PhD in Organic Chemistry from the University of Nottingham, UK.
Jeanita S. Pritchett, Ph.D.
Leadership Coach| STEM Educator| Chemist| Speaker| DE&I Advocate | Entrepreneur
Dr. Jeanita Pritchett is an Academic Program Manager and a Leadership Coach within the federal government. She began her career as a Research Chemist working on developing Standard Reference Materials for clinical, food, and forensics related projects. Prior to her current role, she also worked as a scientific advisor in the federal government and an Embassy Science Fellow for Scifest Africa located in Makhanda, South Africa. Throughout her career, she has remained dedicated to STEM education and inspiring the next generation of STEM professionals. She created a career coaching program for postdocs within her current organization to help them gain clarity about their goals and elevate them towards the next step in their careers. Since its inception in 2018, there have been over 60 participants in the career coaching program. She has over 15 years of experience teaching and currently works as an Adjunct Lecturer of General Chemistry at Montgomery College.
Outside of her full-time work, Dr. Pritchett founded JSP Coaching and Consulting, LLC, a firm that provides leadership and career coaching resources for STEM professionals and organizations. Further, she co-founded Facilitate 2 Motivate (F2M), LLC, a consulting firm focused on helping early- and mid-career professionals achieve success on their own terms. F2M also plays a pivotal role in improving overall organizational cultures through developing diversity, inclusion, and equity strategies and facilitated trainings. As the founder of STEAM Forward! Academy, she also encourages K-12 youth to pursue STEAM (STEM + Arts) subjects with confidence, curiosity, and a genuine sense of belonging through hands-on learning experiences. From inspiring youth to empowering leaders, Dr. Pritchett strives to help others find their place in STEM.
Dr. Pritchett has been the recipient of numerous awards and is a highly sought-after consultant, speaker, and coach. Most recently, she had the distinct honor of having her painting, See it. Believe it. BECOME IT!, featured on the cover of the prestigious research journal Analytical Chemistry. She obtained a B.S. in Chemistry from Tennessee State University, a Ph.D. in Analytical Chemistry from the University of Illinois at Chicago, an Executive Certificate in Leadership Coaching from Georgetown University, and an Executive Certificate in Diversity and Inclusion at Cornell University.
Websites: www.jeanitapritchett.com , www.steamforwardacademy.com , and www.facilitate2motivate.com
Linkedin: Jeanita Pritchett, Ph.D.
Facebook: Jeanita Pritchett, Ph.D.
Youtube: Jeanita Pritchett